U.S. Markets closed

New Strong Sell Stocks for October 5th

Zacks Equity Research
Should investors cheer a political gridlock and bet on these ETFs?

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

AMAG Pharmaceuticals, Inc. AMAG is the developer and manufacturer of therapeutics for maternal and women's health, anemia management and cancer supportive care. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 60 days.

Addus HomeCare Corporation ADUS is a provider of personal care services to the elderly, chronically ill as well as disabled persons. The Zacks Consensus Estimate for its current year earnings has been revised 13.2% downward over the last 60 days.

Anheuser-Busch InBev SA/NV BUD is a producer, distributor and seller of of beer, alcoholic beverages, and soft drinks. The Zacks Consensus Estimate for its current year earnings has been revised 1.7% downward over the last 60 days.

Brooks Automation, Inc. BRKS is a provider of automation and cryogenic solutions for a variety of applications and markets. The Zacks Consensus Estimate for its current year earnings has been revised 3.1% downward over the last 60 days.

Delta Apparel, Inc. DLA is a designer and manufacturer of a plethora of lifestyle basics and branded active wear apparel, headwear and other related accessory products. The Zacks Consensus Estimate for its current year earnings has been revised 6.7% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Brooks Automation, Inc. (BRKS) : Free Stock Analysis Report
 
Anheuser-Busch InBev SA/NV (BUD) : Free Stock Analysis Report
 
AMAG Pharmaceuticals, Inc. (AMAG) : Free Stock Analysis Report
 
Addus HomeCare Corporation (ADUS) : Free Stock Analysis Report
 
Delta Apparel, Inc. (DLA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research